(HealthDay)—For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower with efpeglenatide, an exendin-based glucagon-like peptide ...
Jun 29, 2021
0
2
(HealthDay)—Supplementation with a higher dose of docosahexaenoic acid (DHA) versus the standard prenatal dose during the second half of pregnancy is associated with a lower rate of early preterm births, according to a ...
Jun 21, 2021
0
1
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial published in The Lancet Oncology.
Apr 30, 2021
0
38
High-intensity strength training does not significantly improve knee pain with osteoarthritis compared with low-intensity strength training or a control condition, according to a study published in the Feb. 16 issue of the ...
Feb 17, 2021
0
5
The U.S. Preventive Services Task Force (USPSTF) concludes that there is substantial net benefit for behavioral and pharmacological therapies for smoking cessation, alone or combined. These findings form the basis of a final ...
Jan 20, 2021
0
3
The U.S. Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis ...
Dec 30, 2020
0
3
(HealthDay)—Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study published online Dec. 18 in the New England Journal of Medicine.
Dec 18, 2020
1
3
(HealthDay)—Immune checkpoint inhibitor (ICI) treatment is associated with increased cardiac events among patients with lung cancer and malignant melanoma, according to a study published online Dec. 9 in the European Heart ...
Dec 18, 2020
0
5
Promising results from large clinical trials testing three vaccines to prevent COVID-19 bring us a step closer to a widely available vaccine.
Nov 24, 2020
0
2
(HealthDay)—By treating or preventing infection, glecaprevir and pibrentasvir (G/P) regimens are promising for increasing access to the transplantation of kidneys from hepatitis C virus (HCV)-positive donors to HCV-negative ...
Oct 14, 2020
0
2
